Disease modification in osteoarthritis; pathways to drug approval

OBJECTIVE: To summarize proceedings of a workshop convened to discuss advances in disease modifying osteoarthritis (OA) drugs and regulatory challenges in bringing these drugs to market. DESIGN: Summary of a one day workshop held in Washington, DC in May 2019. RESULTS: Attendees presented data docum...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz, Jeffrey N., Neogi, Tuhina, Callahan, Leigh F., Block, Joel A., Conaghan, Philip G., Simon, Lee S., Kraus, Virginia Byers, Hochberg, Marc C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718177/
https://www.ncbi.nlm.nih.gov/pubmed/36474586
http://dx.doi.org/10.1016/j.ocarto.2020.100059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718177/
https://www.ncbi.nlm.nih.gov/pubmed/36474586
http://dx.doi.org/10.1016/j.ocarto.2020.100059

Ejemplares similares